CRISPR-Cas guides the future of genetic engineering
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
The diversity, modularity, and efficacy of CRISPR-Cas systems are driving a biotechnological revolution. RNA-guided Cas enzymes have been adopted as tools to manipulate the genomes of cultured cells, animals, and plants, accelerating the pace of fundamental research and enabling clinical and agricultural breakthroughs. We describe the basic mechanisms that set the CRISPR-Cas toolkit apart from other programmable gene-editing technologies, highlighting the diverse and naturally evolved systems now functionalized as biotechnologies. We discuss the rapidly evolving landscape of CRISPR-Cas applications, from gene editing to transcriptional regulation, imaging, and diagnostics. Continuing functional dissection and an expanding landscape of applications position CRISPR-Cas tools at the cutting edge of nucleic acid manipulation that is rewriting biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR-Cas9 and related enzymes have been used to manipulate the genomes of cultured cells, animals and plants, vastly accelerating the pace of fundamental research and enabling breakthroughs in agriculture and synthetic biology (reviewed in refs. 6-9).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Cited by
Items 201–300 of 1,000
Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation
Rao, S., Yao, Y., & Bauer, D. E. (2021) · Genome Medicine · doi:10.1186/s13073-021-00857-3 · Cited by 67
trans Single‐Stranded DNA Cleavage via CRISPR/Cas14a1 Activated by Target RNA without Destruction
Wei, Y., Yang, Z., Zong, C., Wang, B., Ge, X., Tan, X., Liu, X., Tao, Z., Wang, P., Ma, C., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202110384 · Cited by 72
Designing Biological Circuits: Synthetic Biology Within the Operon Model and Beyond
English, M. A., Gayet, R. V., & Collins, J. J. (2021) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111914 · Cited by 81
“Just as programmable protein architectures revolutionized the way synthetic biologists approach DNA-level control and redefined the concept of regulator genes, this new generation of modular effectors is having a similar impact, one step further along the central dogma (51) (Figure 3a).”
BackgroundLi, Z., Wang, J., Xu, J.-P., Wang, J., & Yang, X. F. (2023) · Military Medical Research · doi:10.1186/s40779-023-00447-x · Cited by 93
Therapeutic Approaches in Lysosomal Storage Diseases
Fernández-Pereira, C., Millán, B. S., Gallardo‐Gómez, M., Pérez-Márquez, T., Alves-Villar, M., Melcón-Crespo, C., Fernández-Martín, J., & Ortolano, S. (2021) · Biomolecules · doi:10.3390/biom11121775 · Cited by 81
“Genome editing in extracted cells is possible through the action of endonucleases (TALEN system, Zinc-finger nucleases, and the CRISPR-Cas9) that specifically cut the genomic DNA in the mutation locus [49,50].”
BackgroundPotent CRISPR-Cas9 inhibitors from Staphylococcus genomes
Watters, K. E., Shivram, H., Fellmann, C., Lew, R. J., McMahon, B., & Doudna, J. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917668117 · Cited by 70
“C systems are RNA-guided, adaptive immune systems that defend prokaryotes against invading mobile genetic elements (MGEs) (1).”
BackgroundSelf-citationRecent advances in modulating the microbiome
Quigley, E. M. M., & Gajula, P. (2020) · F1000Research · doi:10.12688/f1000research.20204.1 · Cited by 76
Harnessing lipid nanoparticles for efficient CRISPR delivery
Yan, J., Kang, D. D., & Dong, Y. (2021) · Biomaterials Science · doi:10.1039/d1bm00537e · Cited by 72
Zhou, C., Hu, X., Tang, C., Liu, W., Wang, S., Zhou, Y., Zhao, Q., Bo, Q., Shi, L., Sun, X., et al. (2020) · National Science Review · doi:10.1093/nsr/nwaa033 · Cited by 69
Characterization and applications of Type I CRISPR-Cas systems
Hidalgo-Cantabrana, C., & Barrangou, R. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190119 · Cited by 79
Futuristic CRISPR-based biosensing in the cloud and internet of things era: an overview
Ibrahim, A. U., Al-Turjman, F. M., Sa’id, Z., & Özsöz, M. (2020) · Multimedia Tools and Applications · doi:10.1007/s11042-020-09010-5 · Cited by 69
Advances in biological therapies for dyslipidemias and atherosclerosis
Valanti, E.-K., Dalakoura-Karagkouni, K., Siasos, G., Kardassis, D., Eliopoulos, A. G., & Sanoudou, D. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154461 · Cited by 72
CRISPR-based transcriptional activation tool for silent genes in filamentous fungi
Mózsik, L., Hoekzema, M., de Kok, N. A. W., Bovenberg, R. A. L., Nygård, Y., & Driessen, A. J. M. (2021) · Scientific Reports · doi:10.1038/s41598-020-80864-3 · Cited by 72
Application of Genome Editing in Tomato Breeding: Mechanisms, Advances, and Prospects
Salava, H., Thula, S., Mohan, V., Kumar, R., & Maghuly, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020682 · Cited by 73
Transcriptional Activation of Biosynthetic Gene Clusters in Filamentous Fungi
Mózsik, L., Iacovelli, R., Bovenberg, R. A. L., & Driessen, A. J. M. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.901037 · Cited by 72
“Cas proteins commonly cleave double or single stranded DNA, but RNA-cleaving Cas proteins have also been identified (Knott and Doudna, 2018).”
Backgroundvan de Kooij, B., Kruswick, A., van Attikum, H., & Yaffe, M. B. (2022) · Nature Communications · doi:10.1038/s41467-022-32743-w · Cited by 73
“manipulation strategy, (3) quantification of the results in panel 2, and (4) themodel resulting from the data obtained with the reporter construct.”
MethodNucleic acid-assisted CRISPR-Cas systems for advanced biosensing and bioimaging
Chen, S., Gong, B., Zhu, C., Lei, C., & Nie, Z. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.116931 · Cited by 70
Framework‐Hotspot Enhanced Trans Cleavage of CRISPR‐Cas12a for Clinical Samples Detection
Li, F., Li, J., Yang, W., Yang, S., Chen, C., Du, L., Mei, J., Tang, Q., Chen, X., Yao, C., et al. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202305536 · Cited by 80
Liu, H., Dong, J., Duan, Z., Xia, F., Willner, I., & Huang, F. (2024) · Science Advances · doi:10.1126/sciadv.adp6166 · Cited by 75
“…seminal discovery of the clustered regularly interspaced short palindromic repeats (CRISPR) coupled to Cas proteins as genome editing machineries ( 22 – 25 ), through the cis-cleave ability or the collateral trans-cleavage of single-stranded DNA (ssDNA) ( 26 , 27 ), led to the development of…”
Chang, L., Wu, S., & Tian, L. (2019) · Horticulture Research · doi:10.1038/s41438-019-0206-7 · Cited by 71
The CRISPR toolbox in medical mycology: State of the art and perspectives
Morio, F., Lombardi, L., & Butler, G. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008201 · Cited by 68
“cerevisiae keeps expanding the boundaries of potential CRISPR applications [11,68].”
BackgroundStrategies for Efficient Genome Editing Using CRISPR-Cas9
Farboud, B., Severson, A. F., & Meyer, B. J. (2018) · Genetics · doi:10.1534/genetics.118.301775 · Cited by 69
CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson’s Disease
Safari, F., Hatam, G., Behzad‐Behbahani, A., Tabar, V. R., Barekati‐Mowahed, M., Petramfar, P., & Khademi, F. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00761-w · Cited by 67
“Genome editing with CRISPR/Cas9 technology has long been applied to the research and treatment of a range of illnesses such as cancer, various monogenic diseases, AIDS, and central nervous system diseases (Knott and Doudna 2018).”
BackgroundDhole, S., Lloyd, A. L., & Gould, F. L. (2019) · Evolutionary Applications · doi:10.1111/eva.12827 · Cited by 71
The compact Casπ (Cas12l) ‘bracelet’ provides a unique structural platform for DNA manipulation
(2023) · doi:10.1038/s41422-022-00771-2 · Cited by 64
“With excellent engineerable capacity, the CRISPR effectors that provide RNA-guided DNA targeting and cleaving activities are also effectively repurposed as genomic, epigenomic and transcriptional manipulation tools in many organisms.(4,5) Though an increasing number of CRISPR-Cas effectors have confirmed DNA interfere…”
BackgroundHofer, F., Sario, G. D., Musiu, C., Sartoris, S., Sanctis, F. D., & Ugel, S. (2021) · Cells · doi:10.3390/cells10102700 · Cited by 69
“Since its discovery, the CRISPR system has been constantly developed to suit new applications, including the ability to act at the genetic, epigenetic, and RNA levels [243].”
BackgroundGenetic improvement technologies to support the sustainable growth of UK aquaculture
Regan, T. W., Bean, T. P., Ellis, T., Davie, A., Carboni, S., Migaud, H., & Houston, R. D. (2021) · Reviews in Aquaculture · doi:10.1111/raq.12553 · Cited by 63
“Genotyping-in-Thousands by sequencing (GT- seq) A method of comparing specific DNA sequences (genotyping) between up to thousands of individuals simultaneously using a relatively small (~500) panel of SNPs. Genetic Modification (GM) and Genetically Modified Organism (GMO) Changing the genome of an organism by insertin…”
BackgroundInfluentialSu, J., Ke, Y., Maboyi, N., Zhi, X., Yan, S., Li, F., Zhao, B., Jia, X., Song, S., & Ding, X. (2021) · Small Methods · doi:10.1002/smtd.202100935 · Cited by 69
Improvement of base editors and prime editors advances precision genome engineering in plants
Hua, K., Han, P., & Zhu, J. (2021) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiab591 · Cited by 66
Delivering on the promise of gene editing for cystic fibrosis
Hodges, C. A., & Conlon, R. A. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.11.005 · Cited by 69
“It was their simplicity of design which led to widespread adoption in basic research, which in turn led to further improvements in specificity and activity, making them candidates for therapeutic use.(20,21)”
BackgroundAksoy, Y. A., Yang, B., Chen, W., Hung, T., Kuchel, R. P., Zammit, N. W., Grey, S. T., Goldys, E. M., & Deng, W. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c16380 · Cited by 62
Song, M.-K., Park, B.-B., & Uhm, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205010 · Cited by 64
Engineering 3D genome organization
Wang, H., Han, M., & Qi, L. S. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00325-5 · Cited by 68
Wu, Y. S., Zhang, Y., Zhang, X., Luo, S., Yan, X., Qiu, Y., Zheng, L., & Li, L. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112962 · Cited by 61
Genetic Manipulation and Bioreactor Culture of Plants as a Tool for Industry and Its Applications
Kowalczyk, T., Merecz-Sadowska, A., Picot, L., Karačonji, I. B., Wieczfińska, J., Śliwiński, T., & Sitarek, P. (2022) · Molecules · doi:10.3390/molecules27030795 · Cited by 62
Xie, R., Wang, X., Wang, Y., Ye, M., Zhao, Y., Yandell, B. S., & Gong, S. (2022) · Advanced Materials · doi:10.1002/adma.202110618 · Cited by 61
Encapsulating Cas9 into extracellular vesicles by protein myristoylation
Whitley, J. A., Kim, S., Lou, L., Ye, C., Alsaidan, O. A., Sulejmani, E., Cai, J., Desrochers, E., Beharry, Z. M., Rickman, C. B., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12196 · Cited by 62
“Given the promising application of the CRISPR/Cas9 system for the treatment of numerous diseases, one of the major obstacles is to develop an efficient method to deliver the Cas9/sgRNA complex while minimizing off-target effects (Knott & Doudna, 2018).”
Lee, H., Park, J., Kim, N., Youn, W., Yun, G., Han, S. Y., Nguyen, D. T., & Choi, I. S. (2022) · Advanced Materials · doi:10.1002/adma.202201247 · Cited by 61
The CRISPR/Cas9 System Delivered by Extracellular Vesicles
Zhu, X., Gao, M., Yang, Y., Li, W., Bao, J., & Li, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030984 · Cited by 65
“Cas protein and other RNA for shearing DNA [6].”
BackgroundZhu, C., Liu, C., Qiu, X., Xie, S., Li, W., Zhu, L., & Zhu, L. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27334 · Cited by 61
Cas9 deactivation with photocleavable guide RNAs
Zou, R. S., Liu, Y., Wu, B., & Ha, T. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.02.007 · Cited by 63
Gonçalves, E., Behan, F. M., Louzada, S., Arnol, D., Stronach, E. A., Yang, F., Yusa, K., Stegle, O., Iorio, F., & Garnett, M. J. (2019) · Genome biology · doi:10.1186/s13059-019-1637-z · Cited by 60
Functional Features and Current Applications of the RNA‐Targeting Type VI CRISPR‐Cas Systems
Perčulija, V., Lin, J., Zhang, B., & Ouyang, S. (2021) · Advanced Science · doi:10.1002/advs.202004685 · Cited by 70
Jing, X., Arya, V., Reynolds, K. S., & Rogers, H. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.001107 · Cited by 54
“…in 1990, the application of gene therapy in medical intervention has increasingly gained momentum, as highlighted by the invention of clustered regularly interspaced short palindromic repeat (CRISPR) tool in the recent decade (Friedmann 1992, Wirth, Parker et al. 2013, Knott and Doudna 2018).”
BackgroundTranslocation-Related Sarcomas
Nakano, K., & Takahashi, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123784 · Cited by 60
“In preclinical investigations, gene editing technologies have been greatly enhanced by CRISPER-Cas9 (clustered regularly interspaced short palindromic repeats-CRISPR-associated 9) [137].”
Lighting up single-nucleotide variation in situ in single cells and tissues
Zhang, K., Deng, R., Gao, H., Teng, X., & Li, J. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00438f · Cited by 61
CRISPR-based genetic control strategies for insect pests
Yan, Y., Aumann, R. A., Häcker, I., & Schetelig, M. F. (2022) · Journal of Integrative Agriculture · doi:10.1016/j.jia.2022.11.003 · Cited by 60
Genome editing in plants using the compact editor CasΦ
Li, Z., Zhong, Z., Wu, Z., Pausch, P., Al-Shayeb, B., Amerasekera, J., Doudna, J. A., & Jacobsen, S. E. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2216822120 · Cited by 63
Self-citationZhang, Z., Niu, H., Qu, Q., Guo, D., Wan, X., Yang, Q., Mo, Z., Tan, S., Xiang, Q., Xue, T., et al. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2448562 · Cited by 71
“Following DNA cleavage, cellular repair mechanisms can mend the broken DNA strands, enabling researchers to introduce mutations, deletions, or insertions into targeted DNA sequences (Hsu, Lander, and Zhang 2014; Knott and Doudna 2018).”
Ethical issues related to research on genome editing in human embryos
Niemiec, E., & Howard, H. C. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.03.014 · Cited by 64
“tion studies, gene therapy studies, drug development, and production of modified crops in agriculture [1].”
BackgroundIn vivo functional screening for systems-level integrative cancer genomics
Weber, J., Braun, C. J., Saur, D., & Rad, R. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0275-9 · Cited by 64
Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a
Knott, G. J., Cress, B. F., Liu, J.-J., Thornton, B. W., Lew, R. J., Al-Shayeb, B., Rosenberg, D. J., Hammel, M., Adler, B. A., Lobba, M. J., et al. (2019) · eLife · doi:10.7554/elife.49110 · Cited by 59
Self-citationProgesterone: An enigmatic ligand for the mineralocorticoid receptor
Baker, M. E., & Katsu, Y. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113976 · Cited by 58
Multiplexed conditional genome editing with Cas12a in Drosophila
Port, F., Starostecka, M., & Boutros, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004655117 · Cited by 63
“…prokaryotic clustered regularly interspersed short palindromic repeat (CRISPR) - CRISPR associated (Cas) system can be easily programmed to induce DNA double strand breaks (DSBs) at defined loci in the genome of a large variety of organisms (Knott and Doudna 2018; Jinek et al. 2012; Carroll 2014).”
BackgroundEmerging Strategies in TCR-Engineered T Cells
Fang, W., Cheng, X., Xue, J. Z., & Xue, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.850358 · Cited by 65
“Therefore, this CRISPR/Cas9 system holds great promise and may lead the way for future genetic engineering of T cells for cancer immunotherapy (73).”
BackgroundNext-generation cell therapies: the emerging role of CAR-NK cells
Başar, R., Daher, M., & Rezvani, K. (2020) · Hematology · doi:10.1182/hematology.2020002547 · Cited by 62
“The discovery of CRISPR revolutionized the field of gene editing because of its simplicity, efficiency, reproducibility, and low cost.(47) The CRISPR-Cas system is an RNA-mediated bacterial defense system against viruses (bacteriophages) and plasmids that was repurposed for precise RNA-programmable genome editing in m…”
BackgroundEditing the Epigenome to Tackle Brain Disorders
Liu, X. S., & Jaenisch, R. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.10.003 · Cited by 56
“This type of off-target effect could be minimized by introduction of other orthologs for Cas9 with a different PAM sequence, which may enable more sgRNA design options [14,56].”
BackgroundMethodResearch progress on nucleic acid detection and genome editing of CRISPR/Cas12 system
Yang, Y., Wang, D., Lü, P., Ma, S., & Chen, K. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08240-8 · Cited by 58
“CRISPR/Cas12 system involves in genome editing As RNA-guided endonuclease, CRISPR/Cas9 and Cas12a have been widely used for genome editing in animals, plants, and cultured cells, based on their programmable ability to trigger DNA repair at the desired sites, thereby accelerating the pace of basic research and enabling…”
BackgroundEngineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing
Whitley, J. A., & Cai, H. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12343 · Cited by 61
“Excellent reviews about the CRISPR system for genome engineering and biotechnological applications are available (Hsu et al., 2014; Knott & Doudna, 2018).”
BackgroundFukushima, K., & Pollock, D. D. (2023) · Nature Ecology & Evolution · doi:10.1038/s41559-022-01932-7 · Cited by 55
“The rapid development of genome editing technologies with CRISPR/Cas-based systems 1455 (Anzalone et al., 2020; Knott and Doudna, 2018) provides a means to test the effect of mutations on in vivo 1456 phenotypes using targeted mutagenesis.”
MethodSu, A., Liu, Y., Cao, X., Zhao, J., Xu, W., Liang, C., Li, P., & Xu, S. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c05384 · Cited by 55
Cui, J., Luo, Q., Wei, C., Deng, X., Liang, H., Wei, J., Gong, Y., Tang, Q., Zhang, K., & Liao, X. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.342028 · Cited by 55
Phelps, M. (2019) · Molecular Ecology Resources · doi:10.1111/1755-0998.13084 · Cited by 54
“In recent years, CRISPR has proven to be much more than a system for genetic modification of living systems and is now used in a vast number of applications from synthetic biology, targeted DNA sequencing and even DNA data storage technology (Farzadfard & Lu, 2018; Knott & Doudna, 2018).”
BackgroundGoh, Y. J., & Barrangou, R. (2021) · Applied and Environmental Microbiology · doi:10.1128/aem.02669-20 · Cited by 58
Bench-to-bedside: Translational development landscape of biotechnology in healthcare
Liao, C., Xiao, S., & Wang, X. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100097 · Cited by 63
The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer
Takakura, K., Kawamura, A., Torisu, Y., Koido, S., Yahagi, N., & Saruta, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133331 · Cited by 56
“More recently, clustered, regularly interspaced, short palindromic repeat (CRISPR)-directed gene editing technology has been successfully developed for knocking out the targeted gene [116].”
BackgroundGenomics of Plant Disease Resistance in Legumes
Kankanala, P., Nandety, R. S., & Mysore, K. S. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.01345 · Cited by 57
“…of the CRISPR-Cas9 technologies in plant genomes can be found in previous reviews (Cong et al., 2013; Jiang et al., 2013; Perez-Pinera et al., 2013; Shan et al., 2013; Belhaj et al., 2015; Piatek et al., 2015; Kleinstiver et al., 2016; Ma et al., 2016; Tsai and Joung, 2016; Knott and Doudna, 2018).”
CRISPR/Cas9-Mediated miR-29b Editing as a Treatment of Different Types of Muscle Atrophy in Mice
Li, J., Wang, L., Hua, X., Tang, H., Chen, R., Yang, T., Das, S., & Xiao, J. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.03.005 · Cited by 55
A HaloTag-TEV genetic cassette for mechanical phenotyping of proteins from tissues
Rivas‐Pardo, J. A., Li, Y., Mártonfalvi, Z., Tapia‐Rojo, R., Unger, A., Fernández‐Trasancos, Á., Herrero‐Galán, E., Velázquez-Carreras, D., Fernández, J. M., Linke, W. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15465-9 · Cited by 54
“editing technologies (82) will boost insertion of the HaloTag-TEV cassette in different genes 14 coding for mechanical proteins, and enable screenings for biomechanical functions of proteins.”
Activatable CRISPR Transcriptional Circuits Generate Functional RNA for mRNA Sensing and Silencing
Ying, Z., Wang, F., Chu, X., Yu, R., & Jiang, J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004751 · Cited by 55
A Rad51-independent pathway promotes single-strand template repair in gene editing
Gallagher, D. N., Pham, N. T., Tsai, A. M., Janto, N. V., Choi, J., Ira, G., & Haber, J. E. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008689 · Cited by 59
CRISPR technology: The engine that drives cancer therapy
Zhang, M., Eshraghian, E. A., Jammal, O. A., Zhang, Z.-B., & Zhu, X. M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111007 · Cited by 54
Song, G., Zhang, F., Tian, C., Gao, X., Zhu, X., Fan, D., & Tian, Y. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac099 · Cited by 57
“The immune function of CRISPR–Cas generally involves three stages, adaptation, expression and interference, allowing host cells to remember, recognize and destroy re-invading foreign genetic elements (5).”
Structures, Mechanisms, and Functions of His-Me Finger Nucleases
Wu, C.-C., Lin, J. L. J., & Yuan, H. S. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.07.002 · Cited by 58
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy
Pagotto, S., Simeone, P., Brocco, D., Catitti, G., Bellis, D. D., Vespa, S., Pietro, N. D., Marinelli, L., Stefano, A. D., Veschi, S., et al. (2023) · Cancers · doi:10.3390/cancers15041052 · Cited by 53
Advances in Engineering Cells for Cancer Immunotherapy
Xu, X., Li, T., Shen, S., Wang, J., Abdou, P., Gu, Z., & Mo, R. (2019) · Theranostics · doi:10.7150/thno.38583 · Cited by 56
“Genetic engineering aims to change cell phenotypes by altering genetic information [57].”
BackgroundAdenovirus vectors in hematopoietic stem cell genome editing
Li, C., & Lieber, A. (2019) · FEBS Letters · doi:10.1002/1873-3468.13668 · Cited by 58
Combining omics technologies with CRISPR-based genome editing to study food microbes
Pan, M., & Barrangou, R. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.12.027 · Cited by 57
Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics
Ferreira, D., Fontinha, D., Martins, C., Pires, D., Fernandes, A. R., & Baptista, P. V. (2020) · Molecules · doi:10.3390/molecules25153489 · Cited by 61
“Of relevance is also the correct gene editing function but the inefficient targeting to the desired cell or sub-cellular compartment, where nanoparticles have been capable to provide solutions in vectorization [38].”
BackgroundPrecise base editing with CC context-specificity using engineered human APOBEC3G-nCas9 fusions
Liu, Z., Chen, S., Shan, H., Jia, Y., Chen, M., Song, Y., Lai, L., & Li, Z. (2020) · BMC Biology · doi:10.1186/s12915-020-00849-6 · Cited by 54
CRISPR-derived genome editing technologies for metabolic engineering
Nishida, K., & Kondo, A. (2020) · Metabolic Engineering · doi:10.1016/j.ymben.2020.12.002 · Cited by 57
Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect
Chuang, Y.-F., Phipps, A. J., Lin, F., Hecht, V. F. G., Hewitt, A. W., Wang, P., & Liu, G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03725-2 · Cited by 57
Massa, F., Defez, R., & Bianco, C. (2022) · Microorganisms · doi:10.3390/microorganisms10050865 · Cited by 52
Next-Generation Sequencing and CRISPR/Cas13 Editing in Viroid Research and Molecular Diagnostics
Hadidi, A. (2019) · Viruses · doi:10.3390/v11020120 · Cited by 54
“Cas13a provides specificity through CRISPR RNA (crRNA)-target pairing and additional sensitivity due to signal amplification by Cas13a collateral cleavage activity [93].”
BackgroundAbrogation of PRRSV infectivity by CRISPR-Cas13b-mediated viral RNA cleavage in mammalian cells
Cui, J., Techakriengkrai, N., Nedumpun, T., & Suradhat, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-66775-3 · Cited by 54
Accurate Detection and Evaluation of the Gene-Editing Frequency in Plants Using Droplet Digital PCR
Peng, C., Zheng, M., Ding, L., Chen, X., Wang, X., Feng, X., Wang, J., & Xu, J. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.610790 · Cited by 51
“CRISPR-Cas systems have been extensively adapted and used for genome editing and other targeted modifications in organisms (Knott and Doudna, 2018).”
BackgroundMethodInfluentialNucleic acid nanostructure for delivery of CRISPR/Cas9‐based gene editing system
Tang, W., Liu, J., & Ding, B. (2022) · Interdisciplinary medicine · doi:10.1002/inmd.20220014 · Cited by 52
Recent Progress and Challenges in CRISPR-Cas9 Engineered Algae and Cyanobacteria
Patel, V. K., Das, A., Kumari, R., & Kajla, S. (2023) · Algal Research · doi:10.1016/j.algal.2023.103068 · Cited by 50
Covarrubias, S., Vollmers, A. C., Capili, A. M., Boettcher, M., Shulkin, A., Correa, M. R., Halasz, H., Robinson, E. K., O’Briain, L., Vollmers, C., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108541 · Cited by 51
“Clustered regularly interspaced short palindromic repeat (CRISPR) technology has revolutionized the field of functional genomics, providing an easy-to-use method for disrupting specific genes (Knott and Doudna, 2018).”
MethodQiu, Y., Lei, P., Wang, R., Sun, L. D., Luo, Z., Li, S., & Xu, H. L. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108125 · Cited by 51
The post-PAM interaction of RNA-guided spCas9 with DNA dictates its target binding and dissociation
Zhang, Q., Wen, F., Zhang, S., Jin, J., Bi, L., Lü, Y., Li, M., Xi, X., Huang, X., Shen, B., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw9807 · Cited by 53
Allosteric regulation of CRISPR-Cas9 for DNA-targeting and cleavage
Zuo, Z., & Liu, J. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.01.013 · Cited by 54
Reprogramming Acetogenic Bacteria with CRISPR-Targeted Base Editing via Deamination
Xia, P., Casini, I., Schulz, S., Klask, C.-M., Angenent, L. T., & Molitor, B. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00226 · Cited by 50
Cas12a trans-cleavage can be modulated in vitro and is active on ssDNA, dsDNA, and RNA
Fuchs, R. T., Curcuru, J., Mabuchi, M., Yourik, P., & Robb, G. B. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/600890 · Cited by 51
“The effector proteins Cas9 and Cas12a (previously known as Cpf1) from Class 2 Type II and Type V-A CRISPR systems, respectively, use RNA guides to cleave dsDNA in a targeted manner and have been repurposed for genome editing applications in eukaryotic and prokaryotic organisms (6-15).”
BackgroundFluorescence Signal-Readout of CRISPR/Cas Biosensors for Nucleic Acid Detection
Huang, Z., Liu, S., Pei, X., Li, S., He, Y., Tong, Y., & Liu, G. (2022) · Biosensors · doi:10.3390/bios12100779 · Cited by 49
CRISPR/Cas systems accelerating the development of aptasensors
Zhu, C., Zhang, F., Li, H., Chen, Z., Yan, M., Li, L., & Qu, F. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116775 · Cited by 49
Specificity of oligonucleotide gene therapy (OGT) agents
Nedorezova, D. D., Dubovichenko, M. V., Belyaeva, E. P., Grigorieva, E. D., Peresadina, A. V., & Kolpashchikov, D. M. (2022) · Theranostics · doi:10.7150/thno.77830 · Cited by 54
Orsi, E., Nikel, P. I., Nielsen, L. K., & Donati, S. (2023) · Nature Communications · doi:10.1038/s41467-023-42166-w · Cited by 52
“The genome editing revolution brought on by CRISPR-based genetic engineering in the mid 2010s 60 signi fi cantly accelerated the synthetic biology revolution.”
BackgroundZhang, M., Li, H., & Jin, Y. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1364742 · Cited by 73
“The CRISPR/Cas9 system possesses several advantages, including high editing ef fi ciency, ease of operation, cost effectiveness, and diversi fi ed recognition sites, etc. (Doudna and Charpentier, 2014; Knott and Doudna, 2018).”
BackgroundKyrochristos, I. D., & Roukos, D. H. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.101894 · Cited by 54
“Therefore, the revolutionary capacity for precision editing both ex-vivo and in-vivo has delivered a transformative tool in the discovery of novel oncotargets and drugs in pre-clinical studies, while the first early-phase clinical trials on various diseases, including leukemias and solid tumors, implementing genome ed…”
Background
Metadata
- Authors
- Knott, G. J., & Doudna, J. A.
- Affiliations
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Doudna, Jennifer A.
- Venue
- Science
- Published
- 2018-08-31
- Volume
- 361
- Issue
- 6405
- Pages
- 866-869
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6455913
- OpenAlex
- W2888908334
- Cited by
- 1,410
- References
- 76
- Citations by year
- 2026: 92 · 2025: 155 · 2024: 169 · 2023: 177 · 2022: 214 · 2021: 223 · 2020: 205 · 2019: 149 · 2018: 23
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR-Cas, genome editing, transcriptional regulation, CRISPR-Cas diagnostics, agricultural biotechnology
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, RNA, Guide, CRISPR-Cas Systems, Animals, Bacterial Proteins, DNA, Endonucleases, Genetic Engineering, Humans, Plants, RNA, Transcription, Genetic, Molecular Imaging, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.